Results of DEBIFU registry are presented during EuroPCR
Eurocor proudly presents the results of the DEBIFU registry which has been conducted under the lead of Dr. Hubertus von Korn (Neustadt/Weinstraße, Germany).
The poster is presented during this years EuroPCR edition in Paris, level 2, zone D.
This registry investigates the use of drug-eluting balloon in coronary bifurcation lesions. Consult the pdf of the DEBIFU study
Eurocor is a rapidly growing European Life Sciences Technology Corporation specializing in the research, development and manufacture of cardiovascular and endovascular products. Eurocor provides interventional physicians with innovative coronary stent technologies and special cardiovascular and endovascular devices, manufactured in Europe. Products are indicated for minimally cardiovascular and peripheral surgery and comply with biological and biomechanical principles to offer highly flexible, adaptable solutions. Extensive research and development, close clinician collaboration, outstanding quality standard philosophy and global scientific alliances lead to optimization of clinically effective technologies. Eurocor has designed an innovative method for balloon catheter drug delivery with high patient compliance. One heartbeat ahead® – with innovative products such as DIOR® and FREEWAY™.
Eurocor GmbH is a wholly owned subsidiary of Opto Eurocor Healthcare Limited and is part of Opto Circuits Group